In 2016 was created Echo Health Ventures, which is appeared as VC. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Seattle.
Among the most popular portfolio startups of the fund, we may highlight Livongo, DispatchHealth, GNS Healthcare. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Home Health Care, Medical.
We also calculated 10 valuable employees in our database.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2019. Opposing the other organizations, this Echo Health Ventures works on 10 percentage points less the average amount of lead investments. The fund is generally included in less than 2 deals every year. The important activity for fund was in 2019. The average startup value when the investment from Echo Health Ventures is 500 millions - 1 billion dollars. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Echo Health Ventures, startups are often financed by Cambia Health Solutions, Venrock, Threshold. The meaningful sponsors for the fund in investment in the same round are Town Hall Ventures, LRVHealth, HLM Venture Partners. In the next rounds fund is usually obtained by Sandbox Industries, Polaris Partners, LRVHealth.
Related Funds
Funds with similar focus
| Fund Name | Location |
| ALPLA | - |
| Anicom | Japan, Tokyo |
| CareCentrix | Connecticut, East Hartford, United States |
| EVO Venture Partners | Amsterdam, Noord-Holland, The Netherlands |
| Fashion Zone | Canada, Ontario, Toronto |
| Gefen Biomed Investments | Ashkelon, HaDarom, Israel |
| Laboratorios Ordesa | - |
| OAKS Asset Management | India, Maharashtra, Mumbai |
| Qatar Holding | China, Hong Kong, Jordan |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Main Street Health | $315M | 08 Oct 2023 | Nashville, Tennessee, United States | ||
Octave Bioscience | $32M | 26 Jul 2023 | California, United States | ||
Strive Health | $166M | 31 May 2023 | Denver, Colorado, United States | ||
Medix Infusion | $35M | 09 Jan 2023 | Addison, Texas, United States | ||
Upfront Healthcare Services | $10M | 06 Sep 2022 | Chicago, Illinois, United States | ||
Abacus Insights | $28M | 16 Jun 2022 | New York, New York, United States | ||
Waltz Health | $35M | 26 Apr 2022 | Chicago, Illinois, United States | ||
Embold Health | $23M | 16 Mar 2022 | Nashville, Tennessee, United States | ||
Embold Health | $20M | 15 Dec 2021 | Nashville, Tennessee, United States |
– Vori Health announced additional Series A funding from Intermountain Healthcare, Ascension Ventures, and Echo Health Ventures, bringing the total round size to over $50M.
– The round was led by NEA with participation from current investors AlleyCorp and Max Ventures.
– With these strategic partners, Vori Health will continue to expand its full-stack medical offering across the U.S. and will always welcome forward-thinking partners to join forces on this journey to transform care delivery across the nation and beyond.
– Eleanor Health, an outpatient addiction and mental health provider, has closed an oversubscribed $20M Series B financing.
– The company received participation from all existing investors including Town Hall Ventures, Echo Health Ventures, and Mosaic Health Solutions, as well as new participation from Warburg Pincus.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Main Street Health | $315M | 08 Oct 2023 | Nashville, Tennessee, United States | ||
Octave Bioscience | $32M | 26 Jul 2023 | California, United States | ||
Strive Health | $166M | 31 May 2023 | Denver, Colorado, United States | ||
Medix Infusion | $35M | 09 Jan 2023 | Addison, Texas, United States | ||
Upfront Healthcare Services | $10M | 06 Sep 2022 | Chicago, Illinois, United States | ||
Abacus Insights | $28M | 16 Jun 2022 | New York, New York, United States | ||
Waltz Health | $35M | 26 Apr 2022 | Chicago, Illinois, United States | ||
Embold Health | $23M | 16 Mar 2022 | Nashville, Tennessee, United States | ||
Embold Health | $20M | 15 Dec 2021 | Nashville, Tennessee, United States |
